ArticleJournal of thoracic disease2023

Efficacy and safety analysis of anlotinib combined with PD-1 inhibitors in advanced non-small cell lung cancer: a retrospective cohort study.

Xuanting Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.